Medifast (NYSE: MED) reported Q3 EPS of $0.55, $0.04 better than the analyst estimate of $0.51. Revenue for the quarter came in at $77.2 million versus the consensus estimate of $74.94 million.

GUIDANCE:

Medifast sees Q4 2017 EPS of $0.46-$0.49. Medifast sees Q4 2017 revenue of $71.4-74.4 million.

For earnings history and earnings-related data on Medifast (MED) click here.